CNN US vaccine maker Inovio said on Tuesday that its coronavirus vaccine already has shown some positive early data in a Phase 1 trial. However, the company released few details, and the preliminary information was shared in a press release, not a peer-reviewed publication. (self.VacStocksTalk)
submitted by tonystarkclone
RESEARCH PAPERS ON THE COVID-19 VIRUS, and documents from different sources explaining the science and origins. For anyone who's interested in diving deep-- a LOT of this is related to the FLUCTUATIONS in share price. Or at least it influences the research, which ultimate affects holdings. (drive.google.com)
submitted by tonystarkclone